Company profilePharmaceutical#969 of 1,318 in Pakistan✓ No DRAP alerts

Pharma Evo (Pvt) Ltd

Pharmaceutical company · 4 brands · 6 molecules

Ranked #42 of 62 companies in Neuro

4 registered products 6 pharmaceutical brands 6 distinct molecules 0 DRAP alerts

Company overview

4
registered products
6
pharmaceutical brands
6
distinct molecules
6
therapeutic classes
0
DRAP alerts

Pharma Evo (Pvt) Ltd is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 4 product registrations across 6 distinct molecules. Its portfolio is concentrated in Neuro and Gastro. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by Pharma

1 product matched in our catalogue — each with its observed price and DRAP approved ceiling.

Top molecules by brand count

Sacubitril1 brand
Valsartan1 brand
Duloxetine1 brand
Levodopa1 brand
Entacapone1 brand
Carbidopa1 brand

Therapeutic classes

Neuro · 2Gastro · 1Cardiac Care · 1Angiotensin-Ii Antagonists, Combinations · 1Antidepressants · 1Anti-Parkinson Drugs · 1

Conditions treated

Colic/Constipation · 1Hypertension · 1Anxiety/Depression/Insomnia · 1Parkinson'S Disease · 1

Price band (DRAP official ceilings)

Registered products priced by source
DVAGO8 products · Rs 331.1 – Rs 2,593.5
Servaid9 products · Rs 309.96 – Rs 1,659.9
Median across source: Rs 967.49

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

SEARLE PAKISTAN (PVT.) LTD.5 shared molecules
NAVEGAL LABORATORIES4 shared molecules
WILSONS PHARMACEUTICALS3 shared molecules
HILTON PHARMA (PVT) LIMITED3 shared molecules
NBS PHARMA3 shared molecules

Get the full profile for Pharma

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.